Sakae, M. “Buprenorphine: Opioid Agonist-Antagonist for Refractory Pain of Sickle Cell Disease Patients During Hematopoietic Stem Cell Transplant, Uncontrolled By Full-Agonist Opioids”. Journal of Opioid Management, vol. 20, no. 4, Sept. 2024, p. B14, doi:10.5055/bupe.24.rpj.1065.